Description
Release form
Capsules
Packing
50 pcs.
Pharmacological action of
Rovatinex promotes the disintegration and elimination of kidney stones and urinary tract stones. Terpenes, such as Borneol, undergo metabolic changes and are excreted in the urine, mainly in the form of glucuronides, which increases the solubility of calcium salts (the main components of kidney stones and urinary tract stones). In a series of animal experiments, the inhibitory effect of Rovatinex on the formation of kidney stones and urinary tract stones was established.
Rovatinex has an antispasmodic effect, promotes the passage of stones along the urinary tract, reduces pain in renal and ureteric colic, enhances renal blood flow, improving their function and increasing diuresis. It has anti-inflammatory effect, antimicrobial effect (in relation to a number of gram-positive and gram-negative microorganisms), increases the content of protective colloids in the urine and increases the content of glucuronic acid in the urine.
Contraindications
Hypersensitivity to the components of the drug.
Children under 6 years old.
Special instructions
Rovatinex is not recommended for use in patients with severe renal colic, anuria, or severe urinary tract infection. In the process of treatment should increase fluid intake.
Composition
1 capsule contains:
Active ingredients: pinene ( + ) 31 mg camphene 15 mg cineole 3 mg fenhon 4 mg borneol 10 mg anethol 4 mg
Excipient: olive oil
Shell: gelatin glycerol 85% sodium ethyl parahydroxybenzoate sodium propyl parahydroxybenzoate quinoline yellow 1 yellow 10 yellow 10 yellow 4 yellow 10 yellow FCF 85% (E110).
Dosage and Administration Rovatinex
is taken orally before meals.
For adults and children over 14 years of age: Unless otherwise specified by a doctor, the usual dose is 1-2 capsules three times daily before meals. In the case of renal colic, 2-3 capsules four to five times a day.
For children 614 years of age: The usual dose is 1 capsule twice daily before meals.
Side effects
An insignificant number of patients noted mild and transient stomach discomfort.
Vomiting has been very rare.
In two cases, intolerance to the drug was noted (cause unknown).
Drug Interactions
Caution should be exercised when using the drug in patients taking oral anticoagulants or other drugs that undergo metabolism in the liver, if accurate dosing is necessary.
Overdose
Treatment: if the drug is taken recently, it is necessary to rinse the stomach, you should monitor the patient, using symptomatic treatment if necessary. It is recommended to monitor cardiac, respiratory, renal and hepatic functions.
Storage conditions
Do not store above 25 ° C.
active substance
essential oil and extracts of coniferous breeds
Dosage form
capsule
Rova, Ireland
